Literature DB >> 22200185

Atorvastatin, not rosuvastatin, improves cardiac function in heart failure: a meta-analysis of randomized trials.

Hisato Takagi, Takuya Umemoto.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22200185     DOI: 10.1016/j.ijcard.2011.11.079

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


× No keyword cloud information.
  3 in total

1.  Rosuvastatin reduces the recurrence rate following catheter ablation for atrial fibrillation in patients with heart failure.

Authors:  Guojun Zhao; Leiming Wu; Yuzhou Liu; Lu Gao; Yang Chen; Rui Yao; Yanzhou Zhang
Journal:  Biomed Rep       Date:  2017-01-17

2.  No benefits of statins for sudden cardiac death prevention in patients with heart failure and reduced ejection fraction: A meta-analysis of randomized controlled trials.

Authors:  Muaamar Al-Gobari; Hai-Ha Le; Mor Fall; François Gueyffier; Bernard Burnand
Journal:  PLoS One       Date:  2017-02-06       Impact factor: 3.240

Review 3.  Hydrophilic or Lipophilic Statins?

Authors:  Elisenda Climent; David Benaiges; Juan Pedro-Botet
Journal:  Front Cardiovasc Med       Date:  2021-05-20
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.